Nutex Health releases investor presentation outlining micro-hospital expansion strategy
NUTX•Quarterly results and operating metrics
For the three months ended June 30, 2026, net income attributable to Nutex Health was $65.8 million; diluted EPS was $9.38.
Hospital Division visits rose 9.6% to 49,962; net cash from operating activities increased to $34.2 million.
Investor presentation outlines expansion strategy
Nutex Health outlined an expansion strategy centered on micro-hospitals, with 28 facilities opened in 2026 and seven planned for 2026-2027.
Full-year 2025 revenue rose 82.4% to $875.3 million; net income attributable to Nutex Health increased to $70.8 million.
2025 EBITDA increased 70.6% to $168.6 million; adjusted EBITDA jumped 152.6% to $259.6 million.
